Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply

Scott Kopetz; Axel Grothey; Josep Tabernero

doi:10.1056/NEJMc1915676

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply

Scott Kopetz, Axel Grothey, Josep Tabernero

GI Medical Oncology

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	877-878
Number of pages	2
Journal	The New England journal of medicine
Volume	382
Issue number	9
DOIs	https://doi.org/10.1056/NEJMc1915676
State	Published - Feb 27 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1915676

Cite this

@article{b20fd3bfff76438f9da7dabe7126439c,

title = "Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply",

author = "Scott Kopetz and Axel Grothey and Josep Tabernero",

year = "2020",

month = feb,

day = "27",

doi = "10.1056/NEJMc1915676",

language = "English (US)",

volume = "382",

pages = "877--878",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "9",

}

TY - JOUR

T1 - Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply

AU - Kopetz, Scott

AU - Grothey, Axel

AU - Tabernero, Josep

PY - 2020/2/27

Y1 - 2020/2/27

UR - http://www.scopus.com/inward/record.url?scp=85080114334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85080114334&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1915676

DO - 10.1056/NEJMc1915676

M3 - Letter

C2 - 32101678

SN - 0028-4793

VL - 382

SP - 877

EP - 878

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 9

ER -

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this